RENOCRIT 4000

About

Epoetin alfa is a recombinant human erythropoietin, a glycoprotein hormone that stimulates red blood cell production. It functions by binding to erythropoietin receptors on erythroid progenitor cells in the bone marrow, promoting their proliferation and differentiation into mature red blood cells. This mechanism effectively counteracts anemia by increasing hemoglobin levels and red blood cell mass. It is clinically indicated for managing anemia associated with chronic kidney disease, chemotherapy-induced anemia in cancer patients, and for reducing the need for allogeneic red blood cell transfusions in certain surgical settings. Its therapeutic efficacy is closely monitored through regular hemoglobin assessments to ensure optimal response and minimize potential risks.

Uses

• Treatment of anemia due to chronic kidney disease.
• Management of chemotherapy-induced anemia in cancer patients.
• Reduction of allogeneic red blood cell transfusions in surgery.
• Treatment of anemia in zidovudine-treated HIV-infected patients.

Directions For Use

Administer as directed by a healthcare professional, typically via subcutaneous or intravenous injection. Dosage and frequency depend on the specific condition and patient response.

Benefits

• Increases red blood cell count.
• Elevates hemoglobin levels.
• Reduces symptoms of anemia (fatigue, shortness of breath).
• Decreases the need for blood transfusions.
• Improves quality of life for anemic patients.
• Supports erythropoiesis in various clinical settings.

Side Effects

• Hypertension
• Headache
• Fever
• Nausea
• Vomiting
• Diarrhea
• Injection site pain
• Rash
• Thrombosis (blood clots)
• Seizures
• Pure red cell aplasia (rare)
• Allergic reactions

Safety Measures

• Alcohol - No direct interaction, but excessive alcohol can worsen anemia or liver function, which may complicate treatment.
• Pregnancy - Use with caution; benefits must outweigh potential risks. Consult a doctor.
• Breastfeeding - Generally considered safe, but consult a healthcare provider before use.
• Liver - Use with caution in patients with severe liver impairment; monitor liver function.
• Kidney - Primarily used for anemia in chronic kidney disease; dosage adjustments may be needed based on renal function.
• Lung - No specific contraindications related to lung conditions, but monitor for fluid overload in susceptible patients.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.